TAT 2016
21 - 23 Mar 2016
Omni Shoreham, Washington, DC, United States of America
TAT congresses are annual meetings on new molecular targets and innovative cancer therapeutics in the early phases of clinical development, supplemented by associated translational research. Add to these features the high scientific standards, informal atmosphere, and active participation by the world’s leading phase 1 investigators, and you will understand why the TAT Congress series has become the prime international drug development meeting in oncology.
No items were found.